[1] Tang SC, Luo CJ.3-n-butylphthalide on serum VEGF and bFGF levels in acute cerebral infarction[J]. Eur Rev Med Pharmacol, 2017, 21(19): 4431-4436.
[2] Ishibashi K, Kameyama M. Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction[J]. Clin Nucl Med, 2017, 26(10): 1097.
[3] Fu J, Zeng M. Effects of action observation therapy on upper extremity function, daily activities and motion evoked potential in cerebral infarction patients[J]. Medicine (Baltimore), 2017, 96(42): 8080
[4] 郑峥, 陈兴泳. 丁苯酞注射液治疗进展性脑卒中的疗效及安全性研究[J]. 中国全科医学, 2016, 19(03): 322-326.
[5] 国家卫生计生委脑卒中防治工程委员会, 2015中国缺血性脑卒中血脂管理指导规范[S], 2015, 3(2): 311-321.
[6] 王闪闪. 疏血通联合神¾节苷脂注射液治疗脑梗死的临床研究[J]. 湖南师范大学学报 (医学版), 2017, 14(1): 74-77.
[7] 丁志刚, 王青松, 周佩洋, 等. 单唾液酸四己糖神¾节苷脂联合舒血宁对急性脑梗死患者神¾功能的影响及机制研究[J]. 中国中西医结合急救杂志, 2017, 24(2): 158-161.
[8] Ke Z, Zhao Y. The alliance with expanding blood volume and correcting anemia is an effective therapeutic measure for the adult anemia patients of acute cerebral infarction[J]. Int J Neurosci, 2017, 10(15): 1-17.
[9] Chen K, Hou X, et al. The efficacy and safety of endovascular recanalization of occluded large cerebral arteries during the subacute phase of cerebral infarction: a case series report[J]. Stroke Vasc Neurol.2017, 2(3): 124-131.
[10] Janyou A, Wicha P. Dihydrocapsaicin Attenuates Blood Brain Barrier and Cerebral Damage in Focal Cerebral Ischemia/Reperfusion via Oxidative Stress and Inflammatory[J]. Sci Rep, 2017, 7(1): 10556.
[11] 边丽丽, 谷小芳, 刘芳, 等. 依达À奉联合丹红对急性脑梗死患者炎症反应及氧化应激的影响[J]. 医学临床研究, 2017, 34(3): 558-560.
[12] Nishikawa H, Nakatsuka Y. Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage[J]. Transl Stroke Res, 2017, 7(22): 1007.
[13] 高星乐, 陈力宇, 孙乐球, 等. 依达À奉联合丁苯酞治疗急性缺血性脑卒中的临床疗效及安全性评价[J]. 中国临床药理学杂志, 2015(16): 1569-1571.
[14] Li K, Jia J J, Wang Z F, et al. Elevated Serum Levels of NSE and S-100β Correlate with Increased Risk of Acute Cerebral Infarction in Asian Populations[J]. Medical Science Monitor International Medical Journal of Experimental & Clinical Research, 2015, 21: 1879-1888.
[15] 曹苏玲. 早期综合康复护理干预对脑梗死患者神¾功能和生活能力的影响[J]. 中国实用神¾疾病杂志, 2015(17): 119-121.
[16] 左彦方. 辛伐他汀对脑梗死患者血清MDA及SOD的影响[J]. 临床医学, 2015, 35(09): 15-16.
[17] 郑慧芬, 宗惠花. 依达À奉治疗急性脑梗死患者的临床疗效及其对血清SOD、MDA水平的影响[J]. 实用临床医药杂志, 2014, 18(17): 18-21.
[18] 任新光, 李昕. 阿托伐他汀、辛伐他汀对脑梗死患者血清MDA、SOD的影响[J]. 中国实用神¾疾病杂志, 2013, 16(03): 16-18.
[19] Sun Z, Li S, Guo Zl. Effects of Fluoride on SOD and CAT in Testis and Epididymis of Mice[J]. Biological Trace Element Research, 2017, 11(2): 1-6.
[20] 宫健伟, 孙喜灵, 王超云, 等. 四君子汤对脾气虚模型大鼠血清SOD, CAT和GSH-Px及MDA的影响[J]. 时珍国医国药, 2017(1): 46-47.
[21] Zhou Y H, Yu J P, Liu Y F, et al. Effects of Ginkgo biloba Extract on Inflammatory Mediators (SOD, MDA, TNF-α, NF-κBp65, IL-6) in TNBS-InducedColitis in Rats[J]. Mediators of Inflammation, 2017, 2006(5): 1-9.